An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure

Edoxaban and its low-abundance, active metabolite M4 are substrates of P-glycoprotein (P-gp; MDR1) and organic anion transporter protein 1B1 (OATP1B1), respectively, and pharmacological inhibitors of P-gp and OATP1B1 can affect edoxaban and M4 pharmacokinetics (PK). In this integrated pharmacogenomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandell, A G, Lee, J, Shi, M, Rubets, I, Brown, K S, Walker, J R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817390/
https://www.ncbi.nlm.nih.gov/pubmed/27897269
http://dx.doi.org/10.1038/tpj.2016.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817390/
https://www.ncbi.nlm.nih.gov/pubmed/27897269
http://dx.doi.org/10.1038/tpj.2016.82

Ejemplares similares